Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             21 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A comparison of function after limb salvage with non-invasive expandable or modular prostheses in children Ness, Kirsten K.
2014
50 18 p. 3212-3220
9 p.
artikel
2 An exploratory analysis of the factors leading to delays in cancer drug reimbursement in the European Union: The trastuzumab case Ades, Felipe
2014
50 18 p. 3089-3097
9 p.
artikel
3 A randomised, open-label phase II trial of afatinib versus cetuximab in patients with metastatic colorectal cancer Hickish, Tamas
2014
50 18 p. 3136-3144
9 p.
artikel
4 Assessing the impact of evolving evidence in renal cell carcinoma treatment: An update of the Renal Cell Carcinoma Appropriateness-based Treatment Toolkit (ReCATT) Gore, M.E.
2014
50 18 p. 3153-3160
8 p.
artikel
5 Bevacizumab combined with 5-FU/streptozocin in patients with progressive metastatic well-differentiated pancreatic endocrine tumours (BETTER trial) – A phase II non-randomised trial Ducreux, Michel
2014
50 18 p. 3098-3106
9 p.
artikel
6 Bevacizumab plus capecitabine in patients with progressive advanced well-differentiated neuroendocrine tumors of the gastro-intestinal (GI-NETs) tract (BETTER trial) – A phase II non-randomised trial Mitry, Emmanuel
2014
50 18 p. 3107-3115
9 p.
artikel
7 First-line anthracycline-based chemotherapy for angiosarcoma and other soft tissue sarcoma subtypes: Pooled analysis of eleven European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group trials Young, R.J.
2014
50 18 p. 3178-3186
9 p.
artikel
8 Fixed-dose rate gemcitabine alone or alternating with FOLFIRI.3 (irinotecan, leucovorin and fluorouracil) in the first-line treatment of patients with metastatic pancreatic adenocarcinoma: An AGEO randomised phase II study (FIRGEM) Trouilloud, Isabelle
2014
50 18 p. 3116-3124
9 p.
artikel
9 Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: A double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme Moehler, M.
2014
50 18 p. 3125-3135
11 p.
artikel
10 Growth deceleration in children treated with imatinib for chronic myeloid leukaemia Millot, Frédéric
2014
50 18 p. 3206-3211
6 p.
artikel
11 Improved risk stratification by the integration of the revised International Prognostic Scoring System with the Myelodysplastic Syndromes Comorbidity Index van Spronsen, M.F.
2014
50 18 p. 3198-3205
8 p.
artikel
12 Lipoprotein internalisation induced by oncogenic AMPK activation is essential to maintain glioblastoma cell growth Ríos, M.
2014
50 18 p. 3187-3197
11 p.
artikel
13 Long telomere length and a TERT-CLPTM1 locus polymorphism association with melanoma risk Llorca-Cardeñosa, Marta J.
2014
50 18 p. 3168-3177
10 p.
artikel
14 No change in lymph node positivity rate despite increased lymph node yield and improved survival in colon cancer van Erning, F.N.
2014
50 18 p. 3221-3229
9 p.
artikel
15 Non-target progression – The fine line between objectivity and subjectivity Lheureux, Stephanie
2014
50 18 p. 3271-3272
2 p.
artikel
16 Outcome of 3-day bleomycin, etoposide and cisplatin chemotherapeutic regimen for patients with malignant ovarian germ cell tumours: A Taiwanese Gynecologic Oncology Group study Chen, Chi-An
2014
50 18 p. 3161-3167
7 p.
artikel
17 Paclitaxel and bevacizumab with or without capecitabine as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: A multicentre, open-label, randomised phase 2 trial Lam, S.W.
2014
50 18 p. 3077-3088
12 p.
artikel
18 Phase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinoma Milowsky, Matthew I.
2014
50 18 p. 3145-3152
8 p.
artikel
19 PTEN/PIK3CA genes are frequently mutated in spontaneous and medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumours of tree shrews Xia, Hou-Jun
2014
50 18 p. 3230-3242
13 p.
artikel
20 Rapid adherence to collagen IV enriches for tumour initiating cells in oral cancer Liang, Xiao
2014
50 18 p. 3262-3270
9 p.
artikel
21 Synergism of arsenic trioxide and MG132 in Raji cells attained by targeting BNIP3, autophagy, and mitochondria with low doses of valproic acid and vincristine Cavaliere, Victoria
2014
50 18 p. 3243-3261
19 p.
artikel
                             21 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland